Clinical Trials Related to Merck Sharp & Dohme LLC

Related studies linked through entity extraction aliases.

Study to Evaluate the Safety and Efficacy of the Addition of Omarigliptin (MK-3102) Compared With the Addition of Sitagliptin in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-026)

Status: COMPLETED
Phase: PHASE3

Efficacy and Tolerability of Anacetrapib Added to Ongoing Lipid-Lowering Therapy in Adult Participants With Homozygous Familial Hypercholesterolemia (HoFH) (MK-0859-042)

Status: TERMINATED
Phase: PHASE3

Study of Pembrolizumab (MK-3475) Monotherapy in Advanced Solid Tumors and Pembrolizumab Combination Therapy in Advanced Non-small Cell Lung Cancer/ Extensive-disease Small Cell Lung Cancer (MK-3475-011/KEYNOTE-011)

Status: COMPLETED
Phase: PHASE1

Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)

Status: COMPLETED
Phase: PHASE3

Improving Adolescent Vaccination in Appalachian Kentucky

Status: COMPLETED
Phase: NA

Assessment of Intrahepatic Hepatitis C Virus (HCV) RNA Levels at the Time of Liver Transplantation

Status: UNKNOWN
Phase: N/A

The Pharmacokinetics of MK-7145 Following Single Dose Administration in Participants With Moderate Renal Insufficiency (MK-7145-018)

Status: WITHDRAWN
Phase: PHASE1

RAL+ATV/r in Comparison With TDF/FTC (or 3TC) +ATV/r in HIV Infected Patients

Status: UNKNOWN
Phase: PHASE4

A Study of the Safety and Efficacy of Anacetrapib (MK-0859) When Added to Ongoing Statin Therapy in Japanese Participants With Heterozygous Familial Hypercholesterolemia (MK-0859-050)

Status: COMPLETED
Phase: PHASE3

Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS

Status: COMPLETED
Phase: PHASE4

A Study of the Safety and Efficacy of Omarigliptin (MK-3102) in ≥18 and <45 Year-Old Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028)

Status: COMPLETED
Phase: PHASE3

Quality of Life of HIV-infected Participants Switched to Raltegravir Versus Other Antiretroviral Regimens (MK-0518-266)

Status: TERMINATED
Phase: N/A

To Evaluate the Effect of Ritonavir or Omeprazole on the Pharmacokinetics of Samatasvir (IDX719) in Healthy Participants (MK-1894-006)

Status: COMPLETED
Phase: PHASE1

Study to Evaluate Drug-Drug Interaction Between IDX719 and Simeprevir in Healthy Participants (MK-1894-004)

Status: COMPLETED
Phase: PHASE1

Economic Evaluation of Systemic Treatments for Moderate-to-severe Psoriasis

Status: COMPLETED
Phase: N/A

Asenapine for Bipolar Depression

Status: TERMINATED
Phase: PHASE2

Efficacy and Safety of Odanacatib in Postmenopausal Women Previously Treated With Oral Bisphosphonate (MK-0822-076)

Status: TERMINATED
Phase: PHASE3

Impact of Vorinostat on Pruritus Signaling Pathways - Merck Study

Status: WITHDRAWN
Phase: N/A

A Rising Single Dose Study of the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics of MK-8892 (MK-8892-001)

Status: COMPLETED
Phase: PHASE1

The Influence of Hepatic Insufficiency on the Pharmacokinetics of Elbasvir (MK-8742) (MK-8742-009)

Status: COMPLETED
Phase: PHASE1